ARQT vs. PANW

In the year-to-date period, ARQT achieves a 5.67% return, which is significantly higher than PANW's -3.25% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Arcutis Biotherapeutics, Inc. (ARQT) and Palo Alto Networks, Inc. (PANW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ARQT Sharpe Ratio is 0.88, which is comparable to the PANW Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of ARQT and PANW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ARQT nor PANW has paid dividends to shareholders.

The maximum ARQT drawdown since its inception was -95.02%, which is greater than PANW's maximum drawdown of -47.98%. Use the drawdown chart below to compare losses from any high point for ARQT and PANW. For additional features, visit the drawdowns tool.

Arcutis Biotherapeutics, Inc. (ARQT) has a higher volatility of 23.90% compared to Palo Alto Networks, Inc. (PANW) at 19.21%. This indicates that ARQT's price experiences larger fluctuations and is considered to be riskier than PANW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Arcutis Biotherapeutics, Inc. and Palo Alto Networks, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.